A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old

Name: A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old
Published: 2023
License: Public Domain

HI-Bio, A Biogen Company · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

systemic-lupus-erythematosus

lupus nephritis, felzartamab, ln, systemic lupus erythematosus, lupus, refractory ln, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old

Related documents